<?xml version="1.0" encoding="UTF-8"?>
<prs:study_collection xmlns:prs="http://clinicaltrials.gov/prs">
  <clinical_study>
    <id_info>
      <provider_name>NLM_DES</provider_name>
      <provider_study_id>S0006HWA</provider_study_id>
      <org_name>AddenbrookesH</org_name>
      <org_study_id>1234</org_study_id>
    </id_info>
    <is_fda_regulated>No</is_fda_regulated>
    <is_section_801>None</is_section_801>
    <delayed_posting>None</delayed_posting>
    <is_ind_study>No</is_ind_study>
    <ind_info>
      <ind_grantor/>
      <ind_number/>
      <ind_serial_number/>
      <has_expanded_access/>
      <expanded_access_nct_id/>
    </ind_info>
    <brief_title>Test Study for my tool</brief_title>
    <acronym>TEST</acronym>
    <official_title>Test Study for my tool</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      </lead_sponsor>
      <resp_party>
        <resp_party_type>Principal Investigator</resp_party_type>
        <investigator_username>djayne</investigator_username>
        <investigator_title>Dr</investigator_title>
        <investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
        <name_title/>
        <organization/>
        <phone/>
        <phone_ext/>
        <email/>
      </resp_party>
    </sponsors>
    <oversight_info>
      <irb_info>
        <approval_status>Exempt</approval_status>
      </irb_info>
      <has_dmc>No</has_dmc>
      <fda_regulated_drug>No</fda_regulated_drug>
      <fda_regulated_device>No</fda_regulated_device>
      <post_prior_to_approval>None</post_prior_to_approval>
    </oversight_info>
    <brief_summary>
      <textblock>Test Trial </textblock>
    </brief_summary>
    <detailed_description>
      <textblock/>
    </detailed_description>
    <overall_status>Completed</overall_status>
    <why_stopped/>
    <verification_date>2021-07</verification_date>
    <start_date>2020-01-01</start_date>
    <start_date_type>Actual</start_date_type>
    <end_date/>
    <last_follow_up_date>2021-02-01</last_follow_up_date>
    <last_follow_up_date_type>Actual</last_follow_up_date_type>
    <primary_compl_date>2021-01-01</primary_compl_date>
    <primary_compl_date_type>Actual</primary_compl_date_type>
    <study_design>
      <study_type>Interventional</study_type>
      <interventional_design>
        <interventional_subtype>Treatment</interventional_subtype>
        <phase>Phase 2</phase>
        <assignment>Parallel Assignment</assignment>
        <model_description>
          <textblock/>
        </model_description>
        <allocation>Randomized</allocation>
        <masking/>
        <no_masking>true</no_masking>
        <masked_subject>false</masked_subject>
        <masked_caregiver>false</masked_caregiver>
        <masked_investigator>false</masked_investigator>
        <masked_assessor>false</masked_assessor>
        <masking_description>
          <textblock/>
        </masking_description>
        <control/>
        <number_of_arms>2</number_of_arms>
      </interventional_design>
    </study_design>
    <enrollment>400</enrollment>
    <enrollment_type>Actual</enrollment_type>
    <condition>Vasculitis</condition>
    <arm_group>
      <arm_group_label>Control</arm_group_label>
      <arm_type>No Intervention</arm_type>
      <arm_group_description>
        <textblock/>
      </arm_group_description>
    </arm_group>
    <arm_group>
      <arm_group_label>Ritazarem</arm_group_label>
      <arm_type>Experimental</arm_type>
      <arm_group_description>
        <textblock/>
      </arm_group_description>
    </arm_group>
    <intervention>
      <intervention_type>Drug</intervention_type>
      <intervention_name>ritazarem</intervention_name>
      <intervention_description>
        <textblock>A drug that we want to look at</textblock>
      </intervention_description>
      <arm_group_label>Ritazarem</arm_group_label>
    </intervention>
    <eligibility>
      <study_population>
        <textblock/>
      </study_population>
      <sampling_method/>
      <criteria>
        <textblock>Inclusion Criteria:&#13;
  - Vasculitis&#13;
&#13;
Exclusion Criteria:&#13;
  - </textblock>
      </criteria>
      <healthy_volunteers>No</healthy_volunteers>
      <gender>All</gender>
      <gender_based>No</gender_based>
      <gender_description>
        <textblock/>
      </gender_description>
      <minimum_age>18 Years</minimum_age>
      <maximum_age> N/A</maximum_age>
    </eligibility>
    <overall_contact>
      <first_name>Simon</first_name>
      <middle_name/>
      <last_name>Bond</last_name>
      <degrees/>
      <phone>+441223596475</phone>
      <phone_ext/>
      <email>simon.bond@addenbrookes.nhs.uk</email>
    </overall_contact>
    <overall_contact_backup>
      <first_name/>
      <middle_name/>
      <last_name/>
      <degrees/>
      <phone/>
      <phone_ext/>
      <email/>
    </overall_contact_backup>
    <location>
      <facility>
        <name>Cambridge Clinical Trials Unit</name>
        <address>
          <city>Cambridge</city>
          <state/>
          <country>United Kingdom</country>
          <zip>cb20qq</zip>
        </address>
      </facility>
      <status>Completed</status>
      <contact>
        <first_name>Simon</first_name>
        <middle_name/>
        <last_name>Bond</last_name>
        <degrees/>
        <phone>01223596475</phone>
        <phone_ext/>
        <email>simon.bond@addenbrookes.nhs.uk</email>
      </contact>
      <contact_backup>
        <first_name/>
        <middle_name/>
        <last_name/>
        <degrees/>
        <phone/>
        <phone_ext/>
        <email/>
      </contact_backup>
    </location>
    <ipd_sharing_statement>
      <sharing_ipd>No</sharing_ipd>
      <ipd_description>
        <textblock/>
      </ipd_description>
      <ipd_info_type_protocol>false</ipd_info_type_protocol>
      <ipd_info_type_sap>false</ipd_info_type_sap>
      <ipd_info_type_icf>false</ipd_info_type_icf>
      <ipd_info_type_csr>false</ipd_info_type_csr>
      <ipd_info_type_analytic_code>false</ipd_info_type_analytic_code>
      <ipd_time_frame>
        <textblock/>
      </ipd_time_frame>
      <ipd_access_criteria>
        <textblock/>
      </ipd_access_criteria>
      <ipd_url>http://</ipd_url>
    </ipd_sharing_statement>
    <rrs:result xmlns:rrs="http://clinicaltrials.gov/rrs">
      <certainAgreement/>
      <outcomeMeasures>
        <outcomeMeasure>
          <measureRows/>
          <measureDescription/>
          <timeFrame/>
          <title>Time to relapse</title>
          <anticipatedResultPostingDate/>
          <measureType>Primary</measureType>
          <outcomeMeasureAnalyses/>
          <outcomeReportingGroups/>
        </outcomeMeasure>
      </outcomeMeasures>
      <pointOfContact/>
      <reportedEvents>
        <frequentAdverseEvents/>
        <interventionGroups>
          <interventionGroup id="ReportedEvents-InterventionGroup.1">
            <description>control arm</description>
            <title>Control</title>
          </interventionGroup>
          <interventionGroup id="ReportedEvents-InterventionGroup.2">
            <description>ritazarem: A drug that we want to look at</description>
            <title>Ritazarem</title>
          </interventionGroup>
        </interventionGroups>
        <seriousAdverseEvents/>
      </reportedEvents>
    </rrs:result>
  </clinical_study>
</prs:study_collection>
